Dr. Susan Chi, MD
Claim this profileDana-Farber Cancer Institute
Expert in Brain Tumor
Expert in Diffuse Intrinsic Pontine Glioma
28 reported clinical trials
60 drugs studied
About Susan Chi, MD
Education:
- Obtained MD from Harvard Medical School in 2007.
- Completed Residency in Internal Medicine at Brigham and Women's Hospital (2007-2010).
- Undertook Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute/Brigham and Women's Hospital (2010-2013).
Experience:
- Serving as an attending physician at Dana-Farber Cancer Institute.
- Holds the position of Assistant Professor of Medicine at Harvard Medical School.
Area of expertise
1Brain Tumor
Global LeaderStage IV
IDH positive
Stage I
2Diffuse Intrinsic Pontine Glioma
Global LeaderH3.3K27M positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Susan Chi, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Avapritinib
for Pediatric Solid Cancers
This is a Phase 1/2, multicenter, open-label trial of avapritinib in participants 2 to \< 18 years of age with advanced relapsed/refractory (R/R) solid tumors, including central nervous system (CNS) tumors, that harbor a PDGFRA and/or KIT mutation (including non-synonymous point mutations, insertions, and deletions) or amplification, or DMG-H3K27a who have no available curative treatment options. This is a single-arm trial in which all participants will receive avapritinib. The study consists of 2 parts: dose confirmation, safety, and PK (Part 1) and initial efficacy, safety, and PK at the Part 2 recommended dose (Part 2).
Recruiting1 award Phase 1 & 2
More about Susan Chi, MD
Clinical Trial Related4 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Susan Chi, MD has experience with
- Nivolumab
- Temozolomide
- Radiation Therapy
- Etoposide
- Cyclophosphamide
- Ipilimumab
Breakdown of trials Susan Chi, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
- Ribociclib + Everolimus for Brain Tumors
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Glioblastoma
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Chi, MD specialize in?
Susan Chi, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are IDH positive.
Is Susan Chi, MD currently recruiting for clinical trials?
Yes, Susan Chi, MD is currently recruiting for 18 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Susan Chi, MD has studied deeply?
Yes, Susan Chi, MD has studied treatments such as Nivolumab, Temozolomide, Radiation Therapy.
What is the best way to schedule an appointment with Susan Chi, MD?
Apply for one of the trials that Susan Chi, MD is conducting.
What is the office address of Susan Chi, MD?
The office of Susan Chi, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.